Fig. 4
From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
Comparison of eGFR changes between baseline and latest eGFR according to baseline eGFR. Patients are divided into two groups according to degree of eGFR decrease satisfying our definition of renal impairment. Group N (n = 13) shows a sustained decrease in eGFR, particularly at 24 months. Group ND (n = 27) shows no sustained decrease in eGFR, but tends to show a slight decrease that does not meet our definition